Based on our studies in vivo, described above, as well as in vitro studies of other myopathies [230,231,232,233,234], we predicted that mild osmotic shock of dysferlin-null myofibers would cause a higher incidence of abnormal release events, which we could monitor with a Ca2+-sensitive fluorescent dye. Here, DYSF is linked to myopathy.